Skip to main content

OSR Health, Inc.

corporate_fare Company Profile

OSR Health, Inc.

OSRH·OTC·Industrial Applications And Services·CIK 0001840425

As a global healthcare holding company, the company operates with a presence in South Korea, Switzerland, and an office in the United States. It aims to identify, lead, and support the growth of its subsidiaries and potential subsidiary candidates, which are either existing entities or new companies formed through acquiring or licensing assets from industry or academia. The company focuses on innovative research and seeks to pair teams with pharmaceutical or medical device technologies that have the potential to treat diseases and improve healthcare outcomes, providing them with financial and other resources. It evaluates subsidiary candidate opportunities by understanding target indications to identify new approaches and technologies for improved treatment outcomes. The company collaborates with academic and industry leaders, integrating entrepreneurial scientists with business development and leadership teams. Its leadership team supports subsidiaries in transforming discoveries into commercial products. The company's expertise comes from industry veterans, scientists, capital market, and legal professionals. It operates a hub-and-spoke business model, with a centralized executive team partnering with subsidiary management teams to ensure program and corporate alignment.

OSR Health, Inc. (OTC:OSRH) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 28 items for OSRH at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Amended License Agreement Reveals Major Shareholder's $15M Equity Option at 1800% Premium
  • OSR Holdings Secures Up To $815M in VXM01 Licensing Milestones and $30M Development Facility
  • Auditor Raises Going Concern Doubt Amidst Deepening Losses, Internal Control Failures, and Nasdaq Delisting Threat
  • OSR Holdings in Preliminary Talks to Acquire 16% Controlling Stake in Sillajen
  • OSR Holdings Discloses Preliminary Talks for SillaJen Stake & Pexa-Vec Licensing
$0.24 -0.01% today
52-week range · as of 2026-08-25 $0.203 – $1.24
Market cap
$8.43M
Volume
38.8K (0.0× avg)
3-mo avg 1.8M
Live data · 2026-10-04 04:35 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed OSRH - Filings & News (Page 2)

OSRH
Apr 03, 2026, 6:15 AM EDT
Filing Type: 8-K/A
Importance Score:
9
Price at Filing: $0.520
Real-time Price: $0.240 info
Change: -$0.280 (-54%) info
Market Cap: $8.428M info
OSRH
Apr 02, 2026, 3:46 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.51055
Real-time Price: $0.240 info
Change: -$0.27055 (-53%) info
Market Cap: $8.428M info
OSRH
Mar 31, 2026, 4:00 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.603
Real-time Price: $0.240 info
Change: -$0.363 (-60%) info
Market Cap: $8.428M info
OSRH
Mar 16, 2026, 8:29 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.4834
Real-time Price: $0.240 info
Change: -$0.2434 (-50%) info
Market Cap: $8.428M info
OSRH
Mar 16, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.483183
Real-time Price: $0.240 info
Change: -$0.243183 (-50%) info
Market Cap: $8.428M info
OSRH
Mar 05, 2026, 9:30 AM EST
Source: Acceswire
Importance Score:
7
Price at Filing: $0.409
Real-time Price: $0.240 info
Change: -$0.169 (-41%) info
Market Cap: $8.428M info
OSRH
Jan 27, 2026, 9:26 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7496
Real-time Price: $0.240 info
Change: -$0.5096 (-68%) info
Market Cap: $8.428M info
OSRH
Jan 14, 2026, 9:27 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.750
Real-time Price: $0.240 info
Change: -$0.510 (-68%) info
Market Cap: $8.428M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets